Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Cirrhosis
  Free Subscription

Articles published in
Z Gastroenterol
    January 2024
  1. BEDNARSCH J, Lang SA, Heise D, Strnad P, et al
    Laparoscopic Living donor liver transplantation in irresectable intrahepatic cholangiocarcinoma in primary sclerosing cholangitis associated liver cirrhosis.
    Z Gastroenterol. 2024;62:50-55.
    >> Share

  2. GUNDLACH JP, Ellrichmann M, van Rosmalen M, Vogelaar S, et al
    Liver transplantation for HCC in cirrhosis: Are Milan criteria outdated?
    Z Gastroenterol. 2024;62:43-49.
    >> Share

    October 2023
  3. PAZOUKI R, Hasselblatt P, Kugler C
    Prevalence of delirium in gastroenterology/hepatology units: A cross-sectional study.
    Z Gastroenterol. 2023;61:1357-1364.
    >> Share

    May 2023
  4. XIANG Q, Xiong J, Zhao ZJ, Zhou T, et al
    Walking exercise through smartphone application plus branched-chain amino acid supplementation benefits skeletal muscle mass and strength in liver cirrhosis: A prospective control trial.
    Z Gastroenterol. 2023 May 23. doi: 10.1055/a-2075-0130.
    >> Share

  5. WALLSTAB F, Jechorek D, Keitel-Anselmino V, Arnim UV, et al
    [Ligandrol-induced liver injury - Case Report].
    Z Gastroenterol. 2023;61:522-525.
    >> Share

    April 2023
  6. DONG Y, Koch J, Alhyari A, Safai Zadeh E, et al
    Ultrasound Elastography for Characterization of Focal Liver Lesions.
    Z Gastroenterol. 2023;61:399-410.
    >> Share

  7. SLIWINSKI S, Trojan J, Mader C, Vogl T, et al
    Liver resection after Transjugular Portosystemic Stent Shunt (TIPSS).
    Z Gastroenterol. 2023;61:390-393.
    >> Share

    February 2023
  8. DANNECKER FD, Aschenbach R, Teichgraber U, Reuken P, et al
    [Successful therapy of non-cirrhotic non-malignant portal vein thrombosis (NCNMPT) by interventional therapy using transjugular lysis catheter].
    Z Gastroenterol. 2023 Feb 3. doi: 10.1055/a-1967-2223.
    >> Share

    January 2023
  9. ORTNER J, Van Ewijk RJ, Velthuis L, Labenz C, et al
    Costs of a structured early detection program for advanced liver fibrosis and cirrhosis: insights on the "plus" of Check-up 35.
    Z Gastroenterol. 2023 Jan 9. doi: 10.1055/a-1989-1971.
    >> Share

  10. HEINRICH B
    [Innate and adaptive immunity in the context of non-alcoholic fatty liver disease].
    Z Gastroenterol. 2023;61:76-82.
    >> Share

  11. GEIER A, Rau M, Pathil-Warth A, von der Ohe M, et al
    Clinical characteristics of patients with non-alcoholic fatty liver disease (NAFLD) in Germany - First data from the German NAFLD-Registry.
    Z Gastroenterol. 2023;61:60-70.
    >> Share

  12. ROHR L, Lemmer P, Henning M, Tannapfel A, et al
    Patients with NAFLD exhibit more advanced fibrosis in liver biopsy than patients with other chronic liver diseases.
    Z Gastroenterol. 2023;61:29-36.
    >> Share

    November 2022
  13. MOLLER K, Safai Zadeh E, Gorg C, Dong Y, et al
    Prevalence of benign focal liver lesions and non-hepatocellular carcinoma malignant lesions in liver cirrhosis.
    Z Gastroenterol. 2022 Nov 22. doi: 10.1055/a-1890-5818.
    >> Share

  14. GAIRING SJ, Schleicher EM, Muller L, Labenz C, et al
    Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case report.
    Z Gastroenterol. 2022 Nov 15. doi: 10.1055/a-1959-2660.
    >> Share

  15. MUCKE MM, Bruns T, Canbay A, Matzdorff A, et al
    [Use of Thrombopoetin-Receptor-Agonists (TPO-RA) in patients with liver cirrhosis before invasive procedures].
    Z Gastroenterol. 2022 Nov 14. doi: 10.1055/a-1934-1867.
    >> Share

    September 2022
  16. FRUNDT T, Schroder N, Holzemer A, Pinnschmidt H, et al
    Prevalence and risk factors of undiagnosed diabetes mellitus among gastroenterological patients: a HbA1c-based single center experience - Prevalence of undiagnosed diabetes in gastroenterological patients.
    Z Gastroenterol. 2022;60:1306-1313.
    >> Share

    August 2022
  17. DIETRICH CF, Shi L, Lowe A, Dong Y, et al
    Conventional ultrasound for diagnosis of hepatic steatosis is better than believed.
    Z Gastroenterol. 2022;60:1235-1248.
    >> Share

    July 2022
  18. KRUGER K, Rossol S, Krauth C, Buggisch P, et al
    Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R).
    Z Gastroenterol. 2022 Jul 15. doi: 10.1055/a-1852-5713.
    >> Share

    January 2022
  19. KRAG A, Roskams T, Pinzani M, Mueller S, et al
    Diagnostic challenges in patients with alcohol-related liver disease.
    Z Gastroenterol. 2022;60:45-57.
    >> Share

    November 2021
  20. LABENZ C, Kostev K, Galle PR, Worns MA, et al
    Prescription rates of common medications in patients with decompensated cirrhosis in Germany.
    Z Gastroenterol. 2021 Nov 24. doi: 10.1055/a-1676-4822.
    >> Share

  21. KACZMAREK DJ, Kupczyk P, Schultheiss M, Chang J, et al
    TIPS for the management of stomal variceal bleeding due to cirrhotic and non-cirrhotic portal hypertension.
    Z Gastroenterol. 2021 Nov 5. doi: 10.1055/a-1508-6446.
    >> Share

    September 2021
  22. HONER ZU SIEDERDISSEN C, Schultalbers M, Wubbolding M, Lechte GS, et al
    Impact of the COVID-19 pandemic on patients with liver cirrhosis-the experience of a tertiary center in Germany.
    Z Gastroenterol. 2021;59:954-960.
    >> Share

    August 2021
  23. STAHMEYER JT, Hemmerling M, Burger B, Eberhard S, et al
    [Frequency of diagnosed non-alcololic fatty liver disease (NAFLD) in the German population - An analysis based on health insurance data].
    Z Gastroenterol. 2021;59:851-858.
    >> Share

    June 2021
  24. SCURT FG, Bose K, Canbay A, Mertens PR, et al
    [Chronic kidney injury in patients with liver diseases - Reappraising pathophysiology and treatment options].
    Z Gastroenterol. 2021;59:560-579.
    >> Share

    March 2021
  25. KUBESCH A, Peiffer KH, Abramowski H, Dultz G, et al
    The presence of liver cirrhosis is a strong negative predictor of survival for patients admitted to the intensive care unit - Cirrhosis in intensive care patients.
    Z Gastroenterol. 2021 Mar 16. doi: 10.1055/a-1401-2387.
    >> Share

    January 2021
  26. GAIRING SJ, Kloeckner R, Pitton MB, Baumgart J, et al
    Multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension - case-report-based discussion.
    Z Gastroenterol. 2021;59:43-49.
    >> Share

    December 2020
  27. MICHEL M, Schattenberg JM
    [Liver-specific diagnostic for non-alcoholic fatty liver disease (NAFLD) - time to replace liver biopsy?]
    Z Gastroenterol. 2020;58:1233-1240.
    >> Share

    November 2020
  28. MUCKE MM, Miesbach W, Peiffer KH, Mucke VT, et al
    [Management of hemostasis in gastroenterology critical care].
    Z Gastroenterol. 2020;58:1099-1106.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016